D’Angelo, S. P., Furness, A. J. S., Thistlethwaite, F., Burgess, M. A., Riedel, R. F., Haanen, J., … Razak, A. (2024). Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

D’Angelo, Sandra P., Andrew James Scott Furness, Fiona Thistlethwaite, Melissa Amber Burgess, Richard F. Riedel, John Haanen, Jonathan Noujaim, et al. “Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

D’Angelo SP, Furness AJS, Thistlethwaite F, Burgess MA, Riedel RF, Haanen J, et al. Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

D’Angelo, Sandra P., et al. “Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

D’Angelo SP, Furness AJS, Thistlethwaite F, Burgess MA, Riedel RF, Haanen J, Noujaim J, Chalmers AW, Pousa ALPO, Chugh R, Davis LE, Forcade E, Agulnik M, Williams D, Woessner MA, Faitg T, Ireland B, Nathenson MJ, Norry E, Ryan A, Razak A. Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial. JOURNAL OF CLINICAL ONCOLOGY. 2024.